In this episode of Murphys Diesel, we catch up after a three-week break due to snowstorms and the chaotic Wrecker Games.

ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ:IPA) a leader in AI-driven biotherapeutics, announces discovery of a highly ...

A new COVID-19 strain linked to a spike in cases in China has been detected in the U.S., but the CDC says it has seen so few ...

Tracking measles through wastewater is giving health officials a new window into where the virus is spreading.

An Australian Antarctic expedition researching melting ice shelves and ocean currents has found phytoplankton in the depths ...

Last winter’s respiratory syncytial virus, or RSV, season wasn’t as brutal for U.S. babies. A new study suggests two preventive tools — a maternal vaccine and a monoclonal antibody for ...

Respiratory syncytial virus (RSV)–associated hospitalization rates among infants in the United States were significantly lower in the first year when prevention products were widely available ...

RSV prevention products led to a significant reduction in hospitalization rates for infants aged 0 to 7 months during the 2024-2025 season. The maternal RSV vaccine and nirsevimab were key ...

Get Instant Summarized Text (Gist) Widespread use of maternal RSV vaccination and nirsevimab during the 2024–2025 season was linked to significant reductions in RSV-associated hospitalizations ...

As winter nears and the cold and flu season sets in, the highly infectious respiratory virus RSV has again begun its spread. So far this year, the National Disease Surveillance System (NDSS ...

A new study reveals that respiratory syncytial virus (RSV) hospitalizations have significantly higher risks for heart complications than COVID-19-related hospitalizations. This finding ...